These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8378185)

  • 21. Recent advances in the molecular pathogenesis of Ewing's sarcoma.
    Toomey EC; Schiffman JD; Lessnick SL
    Oncogene; 2010 Aug; 29(32):4504-16. PubMed ID: 20543858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunophenotype of Ewing's sarcoma. An immunohistochemical analysis.
    Dierick AM; Roels H; Langlois M
    Pathol Res Pract; 1993 Feb; 189(1):26-32. PubMed ID: 8516214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary renal Ewing's sarcoma.
    Alonso AH; Gárate MM; Amo FH; Iribarren IM; Escudero RM; Sánchez JP; Jiménez JT; Fernández CH
    Arch Esp Urol; 2011 Sep; 64(7):636-9. PubMed ID: 21965263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral primitive neuroectodermal tumors. Diagnosis, classification, and prognosis.
    Tsokos M
    Perspect Pediatr Pathol; 1992; 16():27-98. PubMed ID: 1335143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Round cell tumours of bone.
    Roessner A; Jürgens H
    Pathol Res Pract; 1993 Dec; 189(10):111-36. PubMed ID: 8183732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteosarcomas and Ewing's sarcomas. Comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants.
    Löning T; Liebsch J; Delling G
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(3):323-36. PubMed ID: 3929463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.
    Stephenson CF; Bridge JA; Sandberg AA
    Hum Pathol; 1992 Nov; 23(11):1270-7. PubMed ID: 1330877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructure of the Ewing's sarcoma family of tumors.
    Suh CH; Ordóñez NG; Hicks J; Mackay B
    Ultrastruct Pathol; 2002; 26(2):67-76. PubMed ID: 12036094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence.
    Pagani A; Fischer-Colbrie R; Eder U; Pellin A; Llombart-Bosch A; Bussolati G
    Int J Cancer; 1995 Nov; 63(5):738-43. PubMed ID: 7591294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ewing's sarcoma.
    Granowetter L
    Curr Opin Oncol; 1991 Aug; 3(4):684-8. PubMed ID: 1932228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological study of Ewing's sarcoma/primitive neuroectodermal tumor in oral and maxillofacial region].
    He HW; Liu LK; Li YN; Wang D; He ZX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep; 40(5):379-82. PubMed ID: 16255919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.
    Aryee DN; Ambros I; Ambros PF; Muehlbacher K; Luegmayr A; Yoshie O; Kovar H
    Pediatr Res; 2002 Aug; 52(2):279-85. PubMed ID: 12149507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
    Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
    Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in children.
    Luksch R; Sampietro G; Collini P; Boracchi P; Massimino M; Lombardi F; Gandola L; Giardini R; Fossati-Bellani F; Migliorini L; Pilotti S; Scopsi L
    Tumori; 1999; 85(2):101-7. PubMed ID: 10363075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors.
    Pagani A; Fischer-Colbrie R; Sanfilippo B; Winkler H; Cerrato M; Bussolati G
    Diagn Mol Pathol; 1992 Sep; 1(3):165-72. PubMed ID: 1342962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histogenesis of Ewing's sarcoma. An evaluation of intermediate filaments and endothelial cell markers.
    Miettinen M; Lehto VP; Virtanen I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(3):277-84. PubMed ID: 6135272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.